Viewing Study NCT05277766


Ignite Creation Date: 2025-12-24 @ 4:37 PM
Ignite Modification Date: 2025-12-25 @ 2:27 PM
Study NCT ID: NCT05277766
Status: RECRUITING
Last Update Posted: 2025-07-01
First Post: 2022-02-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer
Sponsor: University Hospital, Ghent
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module